CHOLOGRAFIN MEGLUMINE Drug Patent Profile
✉ Email this page to a colleague
When do Cholografin Meglumine patents expire, and when can generic versions of Cholografin Meglumine launch?
Cholografin Meglumine is a drug marketed by Bracco and is included in one NDA.
The generic ingredient in CHOLOGRAFIN MEGLUMINE is iodipamide meglumine. There is one drug master file entry for this compound. Additional details are available on the iodipamide meglumine profile page.
Summary for CHOLOGRAFIN MEGLUMINE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 4 |
Patent Applications: | 89 |
Formulation / Manufacturing: | see details |
DailyMed Link: | CHOLOGRAFIN MEGLUMINE at DailyMed |
US Patents and Regulatory Information for CHOLOGRAFIN MEGLUMINE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bracco | CHOLOGRAFIN MEGLUMINE | iodipamide meglumine | INJECTABLE;INJECTION | 009321-007 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Bracco | CHOLOGRAFIN MEGLUMINE | iodipamide meglumine | INJECTABLE;INJECTION | 009321-003 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |